TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,353,710 | -32.9% | 161,927 | +20.7% | 0.00% | 0.0% |
| Q2 2023 | $2,017,194 | 0.0% | 134,122 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,017,194 | +9.3% | 134,122 | -14.0% | 0.00% | 0.0% |
| Q4 2022 | $1,845,161 | -99.8% | 155,973 | +10.2% | 0.00% | – |
| Q3 2022 | $838,148,000 | +34.1% | 141,579 | -3.7% | 0.00% | – |
| Q2 2022 | $624,975,000 | -55.0% | 147,053 | +0.8% | 0.00% | -100.0% |
| Q1 2022 | $1,387,329,000 | -37.1% | 145,881 | +25.6% | 0.00% | 0.0% |
| Q4 2021 | $2,206,736,000 | -44.3% | 116,144 | -2.5% | 0.00% | -50.0% |
| Q3 2021 | $3,962,915,000 | -9.1% | 119,078 | +6.0% | 0.00% | 0.0% |
| Q2 2021 | $4,357,784,000 | -12.6% | 112,343 | +8.7% | 0.00% | 0.0% |
| Q1 2021 | $4,983,253,000 | -83.2% | 103,387 | -81.9% | 0.00% | -85.7% |
| Q4 2020 | $29,686,618,000 | +72.5% | 570,677 | -11.2% | 0.01% | +55.6% |
| Q3 2020 | $17,204,889,000 | +30.5% | 642,933 | -5.0% | 0.01% | +12.5% |
| Q2 2020 | $13,183,131,000 | +102.3% | 676,752 | +2.2% | 0.01% | +60.0% |
| Q1 2020 | $6,516,008,000 | -19.8% | 662,196 | -9.5% | 0.01% | 0.0% |
| Q4 2019 | $8,121,837,000 | +122.8% | 731,697 | +12.7% | 0.01% | +150.0% |
| Q3 2019 | $3,644,965,000 | -30.8% | 649,148 | +6.5% | 0.00% | -50.0% |
| Q2 2019 | $5,271,086,000 | +10.3% | 609,374 | +2.5% | 0.00% | 0.0% |
| Q1 2019 | $4,778,967,000 | +77.1% | 594,399 | -9.7% | 0.00% | +100.0% |
| Q4 2018 | $2,698,489,000 | -30.3% | 658,168 | -4.8% | 0.00% | -33.3% |
| Q3 2018 | $3,872,176,000 | -57.7% | 691,460 | -0.8% | 0.00% | -57.1% |
| Q2 2018 | $9,162,815,000 | -32.1% | 696,792 | -26.7% | 0.01% | -36.4% |
| Q1 2018 | $13,503,263,000 | +53.8% | 950,934 | -11.2% | 0.01% | +57.1% |
| Q4 2017 | $8,779,043,000 | -32.1% | 1,070,615 | -1.9% | 0.01% | -41.7% |
| Q3 2017 | $12,926,999,000 | +15.7% | 1,090,886 | -1.8% | 0.01% | +9.1% |
| Q2 2017 | $11,168,536,000 | -37.8% | 1,111,297 | -27.9% | 0.01% | -38.9% |
| Q1 2017 | $17,951,485,000 | +250444.1% | 1,540,900 | +0.0% | 0.02% | +125.0% |
| Q4 2016 | $7,165,000 | -39.8% | 1,540,867 | +0.2% | 0.01% | -38.5% |
| Q3 2016 | $11,899,000 | +8.4% | 1,537,301 | -15.1% | 0.01% | +8.3% |
| Q2 2016 | $10,974,000 | -36.3% | 1,810,844 | -10.4% | 0.01% | -40.0% |
| Q1 2016 | $17,223,000 | -7.2% | 2,021,310 | +30.0% | 0.02% | -4.8% |
| Q4 2015 | $18,553,000 | +1081.7% | 1,555,117 | +898.6% | 0.02% | +950.0% |
| Q3 2015 | $1,570,000 | +492.5% | 155,730 | +873.3% | 0.00% | – |
| Q2 2015 | $265,000 | +44.8% | 16,000 | +35.6% | 0.00% | – |
| Q1 2015 | $183,000 | – | 11,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |